Generalized Hypertrichosis Associated with the Use of Interleukin 17 Blockers in 2 Patients with Psoriasis

    May 2020 in “ JAAD Case Reports ”
    Luis Enrique Sánchez-Dueñas, Lizet K. Rojano-Fritz, Juan C. García-Rodríguez
    Studysummary This report discusses two patients with plaque psoriasis who developed hypertrichosis, or excessive hair growth, while undergoing interleukin-17A inhibitor therapy.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaadcasereports.org →
    Discuss this study in the Community →

    Research cited in this study 5

    1. Generalized Hypertrichosis Due to Secukinumab in a Patient with Moderate Psoriasis: A Case of Serendipity or Zemblanity? Dermatologic therapy · 2019
    2. Excessive Hair Growth in a Patient with Psoriatic Erythroderma Following Secukinumab Administration European Journal of Dermatology · 2018
    3. Repigmentation and New Hair Growth After Anti-Interleukin-17 Therapy with Secukinumab for Psoriasis JAAD Case Reports · 2018
    4. Efalizumab-Induced Hypertrichosis British Journal of Dermatology · 2008
    5. Hypertrichosis Journal of the American Academy of Dermatology · 2003

    Related research 2

    1. Generalized Hypertrichosis Associated with the Use of Interleukin 17 Blockers in 2 Patients with Psoriasis JAAD Case Reports · 2020
    2. Generalized Hypertrichosis Due to Secukinumab in a Patient with Moderate Psoriasis: A Case of Serendipity or Zemblanity? Dermatologic therapy · 2019